Interní Med. 2007; 9(1): 28-30

Vitamin D and immune system - theory and our experience

PharmDr. Klára Sochorová, prof. MUDr. Jiřina Bartůňková DrSc
Ústav imunologie, 2. lékařská fakulta UK a FN Motol, Praha

Vitamin D and its biologically active form kalcitriol participate in a lot of physiological processes in the human body. Calcitriol plays a key role in the regulation of calciumphosporus metabolism and its effect on cell differentiation and immune system is also important. It affects especially the mechanisms of innate immunity, but its activity is very variable. In the case of infection and cancer it works as immunostimulator, while rather as an immunosupressive agent in the case of autoimmunity. Regarding these characteristics, vitamin D can be used to prevent some infectious, malignant and autoimmunity diseases. Calcitriol and its synthetic analogues represent drugs that can bring a benefit into autoimmunity and posttrasplantation treatment. Their therapeutical effect as well as their safety administration in these indications are necessary to be verified in clinical studies.

Keywords: Key words: vitamin D, calcitriol, immunity system.

Published: January 1, 2007  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sochorová K, Bartůňková J. Vitamin D and immune system - theory and our experience. Interní Med. 2007;9(1):28-30.
Download citation

References

  1. Adorini, L. 1,25-Dihydroxyvitamin D3 analogs as potential therapies in transplantation. Curr Opin Investig Drugs 3:1458., 2002.
  2. Adorini, L. Intervention in autoimmunity: the potential of vitamin D receptor agonists. Cell Immunol 233:115, 2005. Go to original source... Go to PubMed...
  3. Adorini, L., S. Amuchastegui, and K. C. Daniel. Prevention of chronic allograft rejection by Vitamin D receptor agonists. Immunol Lett 100:34, 2005. Go to original source... Go to PubMed...
  4. Bartunkova, J., S. Sulkova, T. Fucikova, H. Mareckova, and A. Valek. [The effect of 1,25-dihydroxycholecalciferol on immunity and the clinical state and on parameters of phospho-calcium metabolism in dialyzed patients]. Cas Lek Cesk 129:1102, 1990.
  5. Cantorna, M. T., and B. D. Mahon. 2005. D-hormone and the immune system. J Rheumatol Suppl 76:11, 2005.
  6. Carpenter, K. J., and L. Zhao. Forgotten Mysteries in the Early History of Vitamin D. J. Nutr. 129:923, 1999. Go to original source... Go to PubMed...
  7. Flaig, T. W., A. Barqawi, G. Miller, M. Kane, C. Zeng, E. D. Crawford, and L. M. Glode. A phase II trial of dexamethasone, vitamin D, and carboplatin in patients with hormone-refractory prostate cancer. Cancer 107:266, 2006. Go to original source... Go to PubMed...
  8. Gromer, S. Verdauung und Ernährung. Creaive commons, 2006.
  9. Holick, M. F. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 80:1678S, 2004. Go to original source... Go to PubMed...
  10. Holick, M. F. 2005. Vitamin D for Health and in Chronic Kidney Disease. Seminars In Dialysis 18:266, 2005. Go to original source... Go to PubMed...
  11. Holick, M. F. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 116:2062, 2006. Go to original source... Go to PubMed...
  12. Liu, P. T., S. Stenger, H. Li, L. Wenzel, B. H. Tan, S. R. Krutzik, M. T. Ochoa, J. Schauber, K. Wu, C. Meinken, D. L. Kamen, M. Wagner, R. Bals, A. Steinmeyer, U. Zugel, R. L. Gallo, D. Eisenberg, M. Hewison, B. W. Hollis, J. S. Adams, B. R. Bloom, and R. L. Modlin. Toll-Like Receptor Triggering of a Vitamin D-Mediated Human Antimicrobial Response. Science 311:1770, 2006. Go to original source... Go to PubMed...
  13. Lynch, T. J., J. A. Bogart, W. J. Curran, Jr., M. M. DeCamp, D. R. Gandara, G. Goss, C. I. Henschke, J. R. Jett, B. E. Johnson, K. L. Kelly, T. Le Chevalier, J. L. Mulshine, G. V. Scagliotti, J. H. Schiller, A. Shaw, N. Thatcher, E. E. Vokes, D. E. Wood, and C. Hart. Early stage lung cancer-new approaches to evaluation and treatment: conference summary statement. Clin Cancer Res 11:4981s, 2005. Go to original source... Go to PubMed...
  14. Seibert, E., N. W. Levin, and M. K. Kuhlmann. 2005. Immunomodulating effects of vitamin D analogs in hemodialysis patients. Hemodial Int 9 Suppl 1:S25, 2005. Go to original source... Go to PubMed...
  15. Sochorova K, B. V., Ságová M, Sulková S, Tobiasova Z, Bartunkova J. Vliv analogu vitaminu D parikalcitolu na morfologické a funkční charakteristiky dendritických buněk. Alergie Suppl. 2/2006.
  16. van Etten, E., and C. Mathieu. Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts. J Steroid Biochem Mol Biol 97:93, 2005. Go to original source... Go to PubMed...
  17. Veldman, C. M., M. T. Cantorna, and H. F. DeLuca. Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system. Arch Biochem Biophys 374:334, 2000. Go to original source... Go to PubMed...
  18. Waters, W. R., M. V. Palmer, B. J. Nonnecke, D. L. Whipple, and R. L. Horst. Mycobacterium bovis infection of vitamin D-deficient NOS2-/- mice. Microb Pathog 36:11, 2004. Go to original source... Go to PubMed...
  19. Wingerchuk, D. M., J. Lesaux, G. P. A. Rice, M. Kremenchutzky, and G. C. Ebers. A pilot study of oral kalcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 76:1294, 2005. Go to original source... Go to PubMed...
  20. Zhou, W., R. Suk, G. Liu, S. Park, D. S. Neuberg, J. C. Wain, T. J. Lynch, E. Giovannucci, and D. C. Christiani. Vitamin D is associated with improved survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev 14:2303, 2005. Go to original source... Go to PubMed...




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.